COLL
Collegium Pharmaceutical, Inc. · Healthcare · Drug Manufacturers - Specialty & Generic
Señales de momentum (gestores comparables):
amplitud de titulares -9.1% ·
flujo de acciones +9.5% ·
nuevas posiciones netas -10.0%
— fórmula
Acumulación concentrada — aumento de acciones entre menos titulares
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q1 2025
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q2 2026 | 98 | +3 | 27.25M | $986.22M | +8 | −5 |
| Q1 2026 | 98 | -1 | 28.14M | $930.88M | +7 | −9 |
| Q4 2025 | 100 | 0 | 26.92M | $1.25B | +1 | — |
| Q3 2025 | 19 | +2 | 14.79M | $517.39M | +2 | — |
| Q2 2025 | 14 | +1 | 12.36M | $365.37M | +1 | — |
| Q1 2025 | 10 | -1 | 5.48M | $163.49M | — | −1 |
| Q4 2024 | 11 | -1 | 5.00M | $143.28M | — | −1 |
| Q3 2024 | 11 | -1 | 3.77M | $145.78M | — | −1 |
| Q2 2024 | 12 | — | 3.67M | $118.10M | — | — |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Renaissance Technologies ✦ | 1.62M | -2.7% | $48.24M | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 2 | State Street Global Advisors ✦ (pasivo) | 1.38M | -4.3% | $41.04M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 3 | Geode Capital Management ✦ (pasivo) | 765.53K | -0.6% | $22.86M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 4 | Geode Capital Management ✦ (pasivo) | 765.53K | -0.6% | $22.86M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 5 | Millennium Management ✦ | 647.83K | +248.4% | $19.34M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 6 | Citadel Advisors ✦ | 510.15K | +44.5% | $15.23M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 7 | Citadel Advisors ✦ | 510.15K | +44.5% | $15.23M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 8 | D. E. Shaw & Co. ✦ | 261.13K | +19.9% | $7.79M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 9 | D. E. Shaw & Co. ✦ | 261.13K | +19.9% | $7.79M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 10 | AQR Capital Management ✦ | 107.37K | -30.4% | $3.21M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 11 | AQR Capital Management ✦ | 107.37K | -30.4% | $3.21M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 12 | AQR Capital Management ✦ | 107.37K | -30.4% | $3.21M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 13 | AQR Capital Management ✦ | 107.37K | -30.4% | $3.21M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 14 | AQR Capital Management ✦ | 107.37K | -30.4% | $3.21M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 15 | Wellington Management ✦ | 83.89K | -5.3% | $2.50M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 16 | Wellington Management ✦ | 83.89K | -5.3% | $2.50M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 17 | Two Sigma Investments ✦ | 75.22K | +6.2% | $2.25M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 18 | T. Rowe Price ✦ | 34.54K | +4.2% | $1.03M | 0.0% | ▲ Add | 4 | SEC ↗ |
«Su ponderación» = la participación de la posición en el valor de renta variable 13F declarado por ese gestor — la medida de convicción. ✦ = gestor seleccionado.
Nuevos compradores
| Sin nuevos compradores rastreados este trimestre. |
Posición cerrada
| Gotham Asset Management | $804,320 | era 0.0% |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 1 tenedores, 5.10M acciones, $5.91M declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué otros valores suelen tener también los tenedores rastreados de este activo — recuentos de cotenencia, no relaciones fundamentales.